Zeitschriftenartikel zum Thema „Min yong fei ji“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit Top-25 Zeitschriftenartikel für die Forschung zum Thema "Min yong fei ji" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.
Greco, Venanzio R. „Discussion of “Effects of Strain Localization on Seismic Active Earth Pressures” by Jian-Min Zhang, Fei Song, and De-Ji Li“. Journal of Geotechnical and Geoenvironmental Engineering 137, Nr. 12 (Dezember 2011): 1316. http://dx.doi.org/10.1061/(asce)gt.1943-5606.0000493.
Der volle Inhalt der QuelleZhang, Jian-Min, Fei Song und De-Ji Li. „Closure to “Effects of Strain Localization on Seismic Active Earth Pressures” by Jian-Min Zhang, Fei Song, and De-Ji Li“. Journal of Geotechnical and Geoenvironmental Engineering 137, Nr. 12 (Dezember 2011): 1316–17. http://dx.doi.org/10.1061/(asce)gt.1943-5606.0000594.
Der volle Inhalt der QuelleKim, Joseph, Jai-Hee Moon, Kyung-Mi Lee, Hyun Ryu, Eun Hye Park, Sang Hee Kim, Jeong Seok Kim et al. „Abstract 6219: WM-S1, the novel small molecule inhibitor of mutant RTK/receptor tyrosine kinase, for the treatment of cancer“. Cancer Research 82, Nr. 12_Supplement (15.06.2022): 6219. http://dx.doi.org/10.1158/1538-7445.am2022-6219.
Der volle Inhalt der QuelleB., Ariunbaigali. „“Гуулин улсын судар”-ын тухай“. Mongolian Journal of Foreign Languages and Culture 20, Nr. 450 (02.03.2023): 15–26. http://dx.doi.org/10.22353/mjflc.v20i450.2852.
Der volle Inhalt der QuellePark, Minsu, Tae-Min Cho, Soeun Park, Jung Min Park, Juyeon Seo, Dongmi Ko, Seongjae Kim et al. „Abstract 3712: The C-terminal HSP90 inhibitor, a novel deguelin derivative, exerts anti-metastatic effects in triple-negative breast cancer by targeting cancer stem-like properties“. Cancer Research 82, Nr. 12_Supplement (15.06.2022): 3712. http://dx.doi.org/10.1158/1538-7445.am2022-3712.
Der volle Inhalt der QuelleHoang, Tung, Min Jung Kim, Ji Won Park, Seung-Yong Jeong, Jeeyoo Lee und Aesun Shin. „Abstract 3062: Modifiable factors and gut microbiome alteration among colorectal cancer patients“. Cancer Research 82, Nr. 12_Supplement (15.06.2022): 3062. http://dx.doi.org/10.1158/1538-7445.am2022-3062.
Der volle Inhalt der QuelleRyu, Won-Ji, Shinyoung Park, Jeong Dong Lee, Yumi Hwang, Seongyeon Jo, Kweon Tae Yong, Ja Seung Koo, Min Hwan Kim, Joo Hyuk Sohn und Hyung Seok Park. „Abstract 178: Establishment of patient-derived organoid of breast cancer“. Cancer Research 83, Nr. 7_Supplement (04.04.2023): 178. http://dx.doi.org/10.1158/1538-7445.am2023-178.
Der volle Inhalt der QuelleJung, Eunsun, Seojin Jang, Daeil Sung, Soeun Park, Minsu Park, Dongmi Ko, Seongjae Kim et al. „Abstract 4911: A novel C-terminal of HSP90 inhibitor NCT-547 eliminates cancer stem-like subpopulation in triple-negative breast cancer“. Cancer Research 83, Nr. 7_Supplement (04.04.2023): 4911. http://dx.doi.org/10.1158/1538-7445.am2023-4911.
Der volle Inhalt der QuelleJun, So Yon, Sooyoung Cho, Min Jung Kim, Ji Won Park, Seung Yong Jeong und Aesun Shin. „Abstract 7319: Glycemic traits and colorectal cancer survival in a cohort of South Korean patients: A Mendelian randomization analysis“. Cancer Research 84, Nr. 6_Supplement (22.03.2024): 7319. http://dx.doi.org/10.1158/1538-7445.am2024-7319.
Der volle Inhalt der QuelleLee, Han-Byoel, Ji Gwang Jung, Jung Min Chang, Ji Hyun Chang, Woo Kyung Moon, Kyung Hwan Shin, Il Yong Chung et al. „Abstract OT1-04-02: The NAUTILUS trial (No Axillary sUrgical Treatment In clinically Lymph node negative patients after UltraSonography): A prospective multicenter randomized phase III trial (NCT04303715)“. Cancer Research 82, Nr. 4_Supplement (15.02.2022): OT1–04–02—OT1–04–02. http://dx.doi.org/10.1158/1538-7445.sabcs21-ot1-04-02.
Der volle Inhalt der QuelleKan, Zhengyan, Seock-Ah Im, Kyunghee Park, Ji Wen, Kyung-Hun Lee, Yoon-La Choi, Won-Chul Lee et al. „Abstract PD2-08: Serial genomic profiling reveals molecular mechanisms of breast cancer resistance to palbociclib“. Cancer Research 82, Nr. 4_Supplement (15.02.2022): PD2–08—PD2–08. http://dx.doi.org/10.1158/1538-7445.sabcs21-pd2-08.
Der volle Inhalt der QuelleCheng, Minyi, Liulu Zhang, Yuanqi Chen, Xiaosheng Zhuang, Ciqiu Yang, Fei Ji, Hongfei Gao, Mei Yang, Teng Zhu und Jieqing Li. „Abstract P1-01-03: Feasibility and diagnostic performance of ultrasound assisted carbon nanoparticle suspension versus dual-tracer-guided sentinel lymph node mapping in patients with early breast cancer: A prospective, randomized controlled, phase III clinical trial“. Cancer Research 82, Nr. 4_Supplement (15.02.2022): P1–01–03—P1–01–03. http://dx.doi.org/10.1158/1538-7445.sabcs21-p1-01-03.
Der volle Inhalt der QuelleLee, Eun Ji, Juwon Ahn, You Won Lee, Minyeop Kim, Seung Yeon Oh, Yong Joon Park, Su-Jin Choi et al. „Abstract 6868: Exploring myeloid landscapes according to EGFR mutated NSCLC tumor microenvironment“. Cancer Research 84, Nr. 6_Supplement (22.03.2024): 6868. http://dx.doi.org/10.1158/1538-7445.am2024-6868.
Der volle Inhalt der QuelleZhang, Jian, Dongmei Ji, Li Cai, Herui Yao, Min Yan, Xiaojia Wang, Weina Shen et al. „Abstract P2-13-10: First-in-human HER2-targeted bispecific antibody KN026 for the treatment of patients with HER2-positive metastatic breast cancer: Results from a phase I study“. Cancer Research 82, Nr. 4_Supplement (15.02.2022): P2–13–10—P2–13–10. http://dx.doi.org/10.1158/1538-7445.sabcs21-p2-13-10.
Der volle Inhalt der QuelleShin, Rumi, Byunho Jo, Inyeop Jang, Cheong-Il Shin, Jin Sun Choi, Seung-Yong Jeong, Seung Chul Heo, Ji Won Park, Min Jung Kim und Tae Hyun Hwang. „Abstract 5374: Why only focus on the tumor?: The crucial role of the extra-tumor environment to predict poor responders for locally advanced rectal cancer“. Cancer Research 83, Nr. 7_Supplement (04.04.2023): 5374. http://dx.doi.org/10.1158/1538-7445.am2023-5374.
Der volle Inhalt der QuelleYun, Dabin, Nan Song, Jin-Ah Sim, Min Jung Kim, Ji Won Park, Seung Yong Jeong und Aesun Shin. „Abstract 5234: Novel predictive biomarker SNPs and polygenic risk scores of immune-related genes for colorectal cancer survival in Korea“. Cancer Research 83, Nr. 7_Supplement (04.04.2023): 5234. http://dx.doi.org/10.1158/1538-7445.am2023-5234.
Der volle Inhalt der QuelleHoang, Tung, Min Jung Kim, Ji Won Park, Seung-Yong Jeong und Aesun Shin. „Abstract 2364: Gut microbiome interacts with clinical characteristics on all-cause mortality of colorectal cancer patients“. Cancer Research 83, Nr. 7_Supplement (04.04.2023): 2364. http://dx.doi.org/10.1158/1538-7445.am2023-2364.
Der volle Inhalt der QuelleKim, Jwa Hoon, Soohyeon Lee, Min Hee Hong, Jee Hyun Kim, Eun Joo Kang, Tae-Yong Kim, Yeon Hee Park et al. „Abstract 5209: Hyperprogression in various solid cancers treated with immune checkpoint inhibitors in the real world“. Cancer Research 82, Nr. 12_Supplement (15.06.2022): 5209. http://dx.doi.org/10.1158/1538-7445.am2022-5209.
Der volle Inhalt der QuellePark, Minsu, Soeun Park, Juyeon Seo, Dongmi Ko, Seongjae Kim, Yong Koo Kang, Kee Dal Nam et al. „Abstract 6121: UCP2 inhibitor eradicates cancer stem-like population in trastuzumab-resistant HER2-positive breast cancer“. Cancer Research 83, Nr. 7_Supplement (04.04.2023): 6121. http://dx.doi.org/10.1158/1538-7445.am2023-6121.
Der volle Inhalt der QuellePark, Hyeree, Tung Hoang, Min Jung Kim, Ji Won Park, Seung-Yong Jeong und Aesun Shin. „Abstract 5892: Microbial diversity and composition according to short-term postoperative complication status in colorectal cancer patients“. Cancer Research 83, Nr. 7_Supplement (04.04.2023): 5892. http://dx.doi.org/10.1158/1538-7445.am2023-5892.
Der volle Inhalt der QuellePark, Hyeree, Min Jung Kim, Ji Won Park, Seung-Yong Jeong, Aesun Shin, Sung-Yup Cho, Eun Sung Jung, Dong Ho Suh, Sunyoung Lee und Yu Jin Park. „Abstract 2804: Comparative analysis of microbial diversity and abundance in colorectal cancer patients before and after surgery“. Cancer Research 84, Nr. 6_Supplement (22.03.2024): 2804. http://dx.doi.org/10.1158/1538-7445.am2024-2804.
Der volle Inhalt der QuelleCheng, Ying, Jie Wang, Caicun Zhou, Wenxiu Yao, Qiming Wang, Xuhong Min, Gongyan Chen et al. „Abstract CT038: Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage SCLC: A phase 3 trial“. Cancer Research 82, Nr. 12_Supplement (15.06.2022): CT038. http://dx.doi.org/10.1158/1538-7445.am2022-ct038.
Der volle Inhalt der QuellePark, Su-Bin, Ji-Sik Kang, Min-Je Kim, Shin-Wha Lee, Dong-Woo Kang und Yong-Man Kim. „Abstract 6190: Anti-tumor effects of lenvatinib plus anti-PD-1 in syngeneic murine cervical cancer models“. Cancer Research 82, Nr. 12_Supplement (15.06.2022): 6190. http://dx.doi.org/10.1158/1538-7445.am2022-6190.
Der volle Inhalt der QuelleLee, Dae-Won, Sae-Won Han, Yoojoo Lim, Hwang-Phill Kim, Hanseong Roh, Min Jung Kim, Seung-Bum Ryoo et al. „Abstract 5157: ctDNA change predicts treatment outcome of regorafenib in metastatic colorectal cancer“. Cancer Research 82, Nr. 12_Supplement (15.06.2022): 5157. http://dx.doi.org/10.1158/1538-7445.am2022-5157.
Der volle Inhalt der QuelleRyu, Jai Min, Han-Byoel Lee, Sei Hyun Ahn, Il-Yong Chung, Seeyoun Lee, Seho Park, Woosung Lim et al. „Abstract PS01-03: What to expect from the No axillary surgical treatment for lymph node-negative patients after ultra-sonography [NAUTILUS] trial (KBCSG-21): Clinicopathologic characteristics and axillary lymph node status of enrolled patients“. Cancer Research 84, Nr. 9_Supplement (02.05.2024): PS01–03—PS01–03. http://dx.doi.org/10.1158/1538-7445.sabcs23-ps01-03.
Der volle Inhalt der Quelle